Did you know?

Approximately 50% of US adults have one or more chronic diseases, such as cardiovascular disease.1

assessment-percentage

Unprecedented insights into chronic conditions offer opportunities to improve your health and quality of living.2

Advanced Blood Tests

Singulex’s SMC tests routinely and effectively identify minute quantities of biomarker molecules in blood, enabling precise, confident measurements. Singulex’s advanced lab-developed-tests provide insight into heart health, vascular inflammation and endothelial dysfunction.

Proprietary biomarkers (smc_logocTnI*, smc_logoIL-6*, smc_logoIL-17A*, smc_logoTNF-alpha* and smc_logoEndothelin*) available in our clinical lab, offer unique insight into cardiac function and inflammatory conditions.

advanced_blood_tests

Proven & Validated

homepage_icon2

Singulex SMCTM technology is backed by more than 110 published studies, involving over 60,000 patients, in peer-reviewed publications.

Trusted Results

icon_trustedresults

Since 2010 the Singulex Clinical Laboratory has provided SMC blood test results for approximately half a million patients.

Innovative Technology

icon_innovative

Singulex’s SMC technology reveals what couldn’t be detected before: the power to distinguish people who have disease from those who do not, before symptoms are apparent.2,3

SMC Technology – Up to 100 Times more Sensitive than other Laboratory Testing Platforms, Enables Unprecedented Clinical Insight into Medical Conditions.4,5

SMC_technology

Picogram Elevations in Singulex SMC hs-cTnI were Prognostic in Apparently Healthy Populations

In the Minnesota Heart Survey, it was found that picogram elevations detected by hs-cTnI in an asymptomatic population imparted an 8.5-fold increase in the risk of cardiovascular death.

clinicians_img1

Clinician Support

clinicians_icon4

Singulex offers resources for clinicians to help in the interpretation of results and management of patients. We have a team of medical staff available for consultation.

References:
1 Ward B, et al. Prev Chronic Dis. 2014; 11: 130389.
2 Apple F, et al. Clin Chem. 2012; 58: 930–935.
3 Wang T, et al. Circulation. 2012: 1596–604. Supplemental Material.
4 Apple F, et al. Clin Chem. 2009; 55: 1303-6
5 Validation data on file at Singulex

*This test was developed and its performance characteristic determined by the Singulex Clinical Laboratory. It has not been cleared or approved by the U.S. Food and Drug Administration. The laboratory is regulated under CLIA as qualified to perform high-complexity testing. This test is used for clinical purposes. It should not be regarded as investigational or for research.